Literature DB >> 20693576

Clinical characteristics of patients with persistent atrial fibrillation successfully treated by left atrial ablation.

Yoshihide Takahashi1, Atsushi Takahashi, Taishi Kuwahara, Tadashi Fujino, Kenji Okubo, Shigeki Kusa, Akira Fujii, Atsuhiko Yagishita, Shinsuke Miyazaki, Toshihiro Nozato, Hiroyuki Hikita, Kenzo Hirao, Mitsuaki Isobe.   

Abstract

BACKGROUND: We sought to characterize patients with persistent atrial fibrillation (AF) who were successfully treated by ablation targeting the left atrium (LA). METHODS AND
RESULTS: Ninety-three patients (58±10 years, 79 male) undergoing ablation of persistent AF were studied. During the first procedure, ablation was performed in the LA and coronary sinus, consisting of pulmonary vein isolation, linear ablation, and electrogram-based ablation. During follow-up after the first procedure, 35 patients (38%) remained free from tachyarrhythmias, 27 patients (29%) had atrial tachycardia, and 31 patients (33%) had AF. Duration of persistent AF according to medical history and whether AF was terminated by ablation were associated with the outcome (P=0.005, P=0.004, respectively). In multivariate analysis, the duration of persistent AF was the only predictor of freedom from AF (sinus rhythm or atrial tachycardia) (odds ratio, 0.80 for a 1-year increase; 95% confidence interval, 0.67 to 0.95; P=0.01). Of 31 patients in whom AF recurred during follow-up, electrogram-based ablation was performed in the right atrium in 26 patients. Sixteen of those patients (62%) remained free from AF during follow-up. Overall, 82% of patients were free from any tachyarrhythmias at 2-year follow-up after a median of 2 procedures.
CONCLUSIONS: Patients with shorter duration of persistent AF were more likely to be free from AF by LA ablation. Right atrial ablation may provide incremental efficacy in patients who are refractory to LA ablation.

Entities:  

Mesh:

Year:  2010        PMID: 20693576     DOI: 10.1161/CIRCEP.110.949297

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  10 in total

Review 1.  Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Miki Yokokawa; Hakan Oral; Aman Chugh
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 2.  Prerequisites for Exploring Predictors of Chronic Atrial Fibrillation Recurrence After Ablation.

Authors:  Mahito Noro
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 3.  Atrium-Atrioventricular Node Conduction Block during Catheter Ablation of Persistent Atrial Fibrillation.

Authors:  Yoshihide Takahashi
Journal:  J Atr Fibrillation       Date:  2011-12-20

Review 4.  Catheter Ablation of Long Standing Persistent Atrial Fibrillation: Lessons Learned.

Authors:  Obiora Anusionwu; Hugh Calkins
Journal:  J Atr Fibrillation       Date:  2013-02-12

5.  Effects of two kinds of radio frequency ablations on morphology and function of left atrium in patients with atrial fibrillation.

Authors:  Gang Lin; Xiang-Jun Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation.

Authors:  Huan Meng; Junjie Kou; Ruishuang Ma; Wenbo Ding; Yan Kou; Muhua Cao; Zengxiang Dong; Yayan Bi; Hemant S Thatte; Jialan Shi
Journal:  Mol Med Rep       Date:  2017-10-11       Impact factor: 2.952

7.  Ser96Ala genetic variant of the human histidine-rich calcium-binding protein is a genetic predictor of recurrence after catheter ablation in patients with paroxysmal atrial fibrillation.

Authors:  Michitaka Amioka; Yukiko Nakano; Hidenori Ochi; Yuko Onohara; Akinori Sairaku; Takehito Tokuyama; Chikaaki Motoda; Hiroya Matsumura; Shunsuke Tomomori; Naoya Hironobe; Yousaku Okubo; Sho Okamura; Kazuaki Chayama; Yasuki Kihara
Journal:  PLoS One       Date:  2019-03-06       Impact factor: 3.240

8.  The correlation of pulmonary arterial hypertension with late recurrence of paroxysmal atrial fibrillation after catheter ablation.

Authors:  Yan-Qun Zhang; Fei-Long Zhang; Wei-Wei Wang; Xue-Hai Chen; Jian-Hua Chen; Liang-Long Chen
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

9.  Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation.

Authors:  Gang Lin; Hui-He Lu; Yi Shen; Jian-Fei Huang; Lin-Sheng Shi; Yi-Nan Guo
Journal:  Exp Ther Med       Date:  2013-06-14       Impact factor: 2.447

10.  Role of serum TGF-β1 level in atrial fibrosis and outcome after catheter ablation for paroxysmal atrial fibrillation.

Authors:  Ye Tian; Yubin Wang; Weijie Chen; Yuehui Yin; Mu Qin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.